Grade 3 Follicular Lymphoma
Associated Genetic Biomarkers
NCI Definition: A follicular lymphoma which contains more than 15 centroblasts per 40X high-power microscopic field. 
There are 2 clinical trials for grade 3 follicular lymphoma, of which 2 are open and 0 are completed or closed. Of the trials that contain grade 3 follicular lymphoma as an inclusion criterion, 2 are phase 2 (2 open).
Carboplatin, etoposide, and ifosfamide are the most common interventions in grade 3 follicular lymphoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 6. This dataset does not represent the totality of the genetic landscape; see paper for more information.